logo

Hikal Ltd. Financials

10:19 Jun 19

Hikal Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
363.90
-1.65 (-0.45%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Hikal Ltd. Financials

Hikal Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
363.90
-1.65 (-0.45%)
10:19 Jun 19
Quality
image/svg+xml

79/100
High Financial Strength

Valuation
image/svg+xml

44/100
Mid Valuation

Technical

41/100
Technically Neutral

Strength

6

Weakness

4

Opportunity

0

Threats

0

7.19 %

ROE %

3.59 %

ROA %

7.36

EPS

102.21

BVPS

4.88 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
1720.44 1942.72 2023.03 1784.6 1859.8
Operating Expenses +
1397.55 1602.16 1765.97 1517.57 1531.4
Raw Material
906.71 1032.21 1121.59 805.15 882.6
Increase Decrease in Cost
1.66 -35.82 -14.56 19.51 -45.3
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
164.32 203.38 222.44 246.53 247.1
Miscellaneous Expenses
324.86 402.39 436.5 446.38 447
Operating Profit
322.89 340.56 257.06 267.03 328.4
Other Income
4.98 4.89 5.41 2.45 5
Depreciation
85.24 95.67 109.01 117.61 134.4
Interest
36.2 31.22 48.1 56.37 75.2
Profit before tax and exceptio..
206.42 218.56 105.36 95.5 123.8
Exceptional Items
0 0 0 0 0
PBT
206.42 218.56 105.36 95.5 123.8
Provision for Taxation
73.28 58.06 26.98 25.9 33
Net Profit
133.14 160.5 78.38 69.6 90.8
NET Profit after MI
133.14 160.5 78.38 69.6 90.8
EPS
10.8 13.02 6.36 5.64 7.36
Operating Profit Margin (%)
18.77 17.53 12.71 14.96 17.66
Net Profit Margin (%)
7.74 8.26 3.87 3.9 4.88

Hikal Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 68.80 68.80 68.80 68.80 68.80
FII 5.70 6.10 6.80 6.70 6.60
MF 2.90 2.90 3.20 2.70 3.00
Others 0.90 0.50 0.40 0.40 0.50
Shareholder Shares Holding %
Research 360 logo
Download Our App On: